Clinical Trial Update: A Study of XY03-EA Tablets in the Treatment of Acute Ischemic Stroke [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial evaluating XY03-EA tablets for acute ischemic stroke is currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• XY03-EA Tablets

Snippet

Sponsor: Shijiazhuang Yiling Pharmaceutical Co. Ltd | Conditions: Stroke, Ischemic | Phase 2, Phase 3 | Status: ENROLLING_BY_INVITATION